A higher dose of Wegovy has received final regulatory clearance in the EU, marking a significant step for obesity treatment. The approval allows physicians to prescribe a weekly 7.2 mg dose, administered as Eli Lilly has dropped the cost for lower doses of its popular weight loss drug Zepbound but just for people who pay out of pocket. Without insurance, the list price for a month's Semaglutide vs Retatrutide CVS Caremark is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. DETAILS How Much Does a Medical Weight Loss Cost? Dr. Shima Hadidchi These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022